Sign up USA
Proactive Investors - Run By Investors For Investors
Markets

US Risers & Fallers: Morgan Stanley, UnitedHealth, J&J, Amarantus, Avant, Payment Data

Below are some of the main news-driven share price changes as at 11:33 a.m. in New York.
rsz_shutterstock_156889127.jpg
Avant Diagnostics rises, Amarantus BioScience falls.

RISERS

Morgan Stanley (NYSE:MS) rose 2.6% to $26.65 after swinging to a profit in the fourth quarter.

UnitedHealth (NYSE:UNH) advanced 3.5% to $112.93 after posting fourth-quarter earnings per share of $1.40 and revenue of $43.6bn.

Johnson & Johnson (NYSE:JNJ) rose 0.9% to $97.88 after saying it will cut up to 6% of its workforce in its medical-devices division.

FALLERS

Amarantus BioScience Holdings (OTCMKTS:AMBS) fell 25% to $0.276, reversing an earlier gain. The biotechnology company entered into a letter of intent with Avant Diagnostics (OTCBB:AVDX), a medical diagnostic technology company, to merge an Amarantus wholly-owned unit, Amarantus Diagnostics, into Avant Diagnostics. Shares of Avant rose 195 to $0.25.

Payment Data Systems (NASDAQ:PYDS) slid 1% to $2.08, erasing an earlier gain. The integrated payment solutions provider announced record transaction processing results for the fourth quarter and year ended December 31, 2015.


Copyright © Proactiveinvestors.com, 2016. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC